IL17A and infection: Protected mice received an intranasal B. pertussis challenge 56 days after the primary infection (D0) and showed increased percentages of IFNγ- and IL-17A-producing Prn-specific CD4+ CD44+ T-cells on 10 days p.c. compared to the percentage in naive mice.